TY - JOUR
T1 - Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier
AU - Kubo, Yoshiyuki
AU - Kusagawa, Yusuke
AU - Tachikawa, Masanori
AU - Akanuma, Shin Ichi
AU - Hosoya, Ken Ichi
N1 - Funding Information:
We would like to thank Kowa Co., Ltd. for providing nipradilol. The present study was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), Health and Welfare Department of Toyama Prefectural Government (Toyama, Japan), and Mochida Memorial Foundation (Tokyo, Japan).
PY - 2013/3
Y1 - 2013/3
N2 - Purpose: To clarify the transport and inhibition characteristics involved in verapamil transport across the inner blood-retinal barrier (inner BRB). Methods: The transport of [3H]verapamil across the inner BRB was investigated using retinal uptake index and integration plot analyses in rats. The detailed transport characteristics were studied using TR-iBRB2 cells, a conditionally immortalized rat retinal capillary endothelial cell line that is an in vitro model of the inner BRB. Results: The apparent influx permeability clearance of [3H]verapamil was 614 μL/(min·g retina), which is 4.7-fold greater than that of brain. The retinal uptake of [ 3H]verapamil was slightly increased by 3 mM verapamil and 10 mM qunidine and inhibited by 40 mM pyrilamine, supporting the carrier-mediated efflux and influx transport of verapamil across the inner BRB. TR-iBRB2 cells exhibited a concentration-dependent uptake of [3H]verapamil with a K m of 61.9 μM, and the uptake was inhibited by several cations, such as pyrilamine, exhibiting a different profile from the identified transporters. These transport properties suggest that verapamil transport at the inner BRB takes place via a novel organic cation transporter. Conclusions: Our findings suggest that a novel organic cation transporter is involved in verapamil transport from the blood to the retina across the inner BRB.
AB - Purpose: To clarify the transport and inhibition characteristics involved in verapamil transport across the inner blood-retinal barrier (inner BRB). Methods: The transport of [3H]verapamil across the inner BRB was investigated using retinal uptake index and integration plot analyses in rats. The detailed transport characteristics were studied using TR-iBRB2 cells, a conditionally immortalized rat retinal capillary endothelial cell line that is an in vitro model of the inner BRB. Results: The apparent influx permeability clearance of [3H]verapamil was 614 μL/(min·g retina), which is 4.7-fold greater than that of brain. The retinal uptake of [ 3H]verapamil was slightly increased by 3 mM verapamil and 10 mM qunidine and inhibited by 40 mM pyrilamine, supporting the carrier-mediated efflux and influx transport of verapamil across the inner BRB. TR-iBRB2 cells exhibited a concentration-dependent uptake of [3H]verapamil with a K m of 61.9 μM, and the uptake was inhibited by several cations, such as pyrilamine, exhibiting a different profile from the identified transporters. These transport properties suggest that verapamil transport at the inner BRB takes place via a novel organic cation transporter. Conclusions: Our findings suggest that a novel organic cation transporter is involved in verapamil transport from the blood to the retina across the inner BRB.
KW - P-glycoprotein
KW - inner blood-retinal barrier
KW - lipophilic basic drug
KW - organic cation transporter
UR - http://www.scopus.com/inward/record.url?scp=84878845735&partnerID=8YFLogxK
U2 - 10.1007/s11095-012-0926-y
DO - 10.1007/s11095-012-0926-y
M3 - 学術論文
C2 - 23179781
AN - SCOPUS:84878845735
SN - 0724-8741
VL - 30
SP - 847
EP - 856
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 3
ER -